Using mendelian randomisation to infer causality in depression and anxiety research

Depression and Anxiety

Volumn 30, Issue 12, 2013, Pages 1185-1193

  Gage, Suzanne H ^a   Smith, George Davey ^a   Zammit, Stanley ^b   Hickman, Matthew ^a   Munafò, Marcus R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

causal inference; genetics; instrumental variable; substance use

Indexed keywords

ANXIETY; BODY MASS; CAUSAL ATTRIBUTION; CHROMOSOME 15; DEPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MENDELIAN RANDOMIZATION ANALYSIS; NONHUMAN; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

CAUSAL INFERENCE; GENETICS; INSTRUMENTAL VARIABLE; SUBSTANCE USE;

ANXIETY DISORDERS; CAUSALITY; DEPRESSIVE DISORDER; HUMANS; LINKAGE DISEQUILIBRIUM; MENDELIAN RANDOMIZATION ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RESEARCH DESIGN; SMOKING; SUBSTANCE-RELATED DISORDERS;

EID: 84889861295     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22150     Document Type: Review

References (60)

1. Rao U,. Links between depression and substance abuse in adolescents: neurobiological mechanisms. Am J Prevent Med 2006; 31 (6 Suppl 1): S161-S174. Epub 2006/12/19.
2. Farrell M, Howes S, Bebbington P, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001; 179: 432-437. Epub 2001/11/02. (Pubitemid 33097166)
3. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61 (8): 807-816. Epub 2004/08/04. (Pubitemid 39031120)
4. Rubino T, Zamberletti E, Parolaro D,. Adolescent exposure to cannabis as a risk factor for psychiatric disorders. J Psychopharmacol 2012; 26 (1): 177-188. Epub 2011/07/20.
5. Davey Smith G, Phillips AN, Neaton JD,. Smoking as " independent" risk factor for suicide: illustration of an artifact from observational epidemiology? Lancet 1992; 340 (8821): 709-712. Epub 1992/09/19.
6. Davey Smith G, Ebrahim S,. Data dredging, bias, or confounding. BMJ 2002; 325 (7378): 1437-1438. Epub 2002/12/21. (Pubitemid 36026785)
7. Stampfer MJ, Colditz GA,. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20 (1): 47-63. Epub 1991/01/01.
8. Beral V, Banks E, Reeves G,. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002; 360 (9337): 942-944. Epub 2002/10/02. (Pubitemid 35283842)
9. Rutter M, working group A. Identifying the environmental causes of disease: how should we decide what to believe and how to take action? Acad Med Sci 2007.
10. Tsuang MT, Francis T, Minor K, Thomas A, Stone WS,. Genetics of smoking and depression. Hum Gen 2012; 131 (6): 905-915. Epub 2012/04/25.
11. Markou A, Kosten TR, Koob GF,. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998; 18 (3): 135-174. Epub 1998/02/21. (Pubitemid 28062580)
12. Rose JE, Behm FM, Ramsey C, Ritchie JC, Jr,. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms. Nicotine Tob Res 2001; 3 (4): 383-390. Epub 2001/11/06. (Pubitemid 33101065)
13. Saal D, Dong Y, Bonci A, Malenka RC,. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003; 37 (4): 577-582. (Pubitemid 36262980)
14. Kapur S, Mizrahi R, Li M,. From dopamine to salience to psychosis-linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 2005; 79 (1): 59-68. Epub 2005/07/12. (Pubitemid 41362593)
15. Laje RP, Berman JA, Glassman AH,. Depression and nicotine: preclinical and clinical evidence for common mechanisms. Curr Psychiatr Rep 2001; 3 (6): 470-474. Epub 2001/11/15.
16. Djuric VJ, Dunn E, Overstreet DH, Dragomir A, Steiner M,. Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines. Physiol Behav 1999; 67 (4): 533-537. Epub 1999/11/05. (Pubitemid 29488531)
17. Vazquez-Palacios G, Bonilla-Jaime H, Velazquez-Moctezuma J,. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Progress Neuropsychopharmacol Biol Psychiatry 2005; 29 (1): 39-46. Epub 2004/12/22. (Pubitemid 40018203)
18. Nestler EJ, Hyman SE,. Animal models of neuropsychiatric disorders. Nat Neurosci 2010; 13 (10): 1161-1169. Epub 2010/09/30.
19. Salin-Pascual RJ, de la, Fuente JR, Galicia-Polo L, Drucker-Colin R,. Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology (Berl) 1995; 121 (4): 476-479. Epub 1995/10/01.
20. Salin-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V,. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 1996; 57 (9): 387-389. Epub 1996/09/01. (Pubitemid 26321988)
21. Davey Smith G, Ebrahim S,. What can Mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005; 330 (7499): 1076-1079. Epub 2005/05/10. (Pubitemid 40646565)
22. Davey Smith G, Ebrahim S,. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32 (1): 1-22. Epub 2003/04/12. (Pubitemid 36503465)
23. Davey Smith G,. Mendelian randomization for strengthening causal inference in observational studies: application to gene x environment interactions. Perspect Psychol Sci 2010; 5 (5): 527-545.
24. Davey Smith G, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S,. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. Plos Med 2007; 4 (12): e352. Epub 2007/12/14.
25. Davey Smith G,. Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health. Genes Nutr 2011; 6 (1): 27-43. Epub 2011/03/26.
26. Sheehan NA, Didelez V, Burton PR, Tobin MD,. Mendelian randomisation and causal inference in observational epidemiology. Plos Med 2008; 5 (8): e177. Epub 2008/08/30.
27. Koopmans JR, Slutske WS, Heath AC, Neale MC, Boomsma DI,. The genetics of smoking initiation and quantity smoked in Dutch adolescent and young adult twins. Behav Gen 1999; 29 (6): 383-393. Epub 2000/06/17. (Pubitemid 30368316)
28. Li MD, Cheng R, Ma JZ, Swan GE,. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003; 98 (1): 23-31. Epub 2002/12/21. (Pubitemid 36044333)
29. Saccone SF, Hinrichs AL, Saccone NL, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human Mol Gen 2007; 16 (1): 36-49. Epub 2006/12/01. (Pubitemid 46152543)
30. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452 (7187): 638-642. Epub 2008/04/04. (Pubitemid 351483366)
31. Thorgeirsson TE, Gudbjartsson DF, Surakka I, et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Gen 2010; 42 (5): 448-453. Epub 2010/04/27.
32. Timofeeva MN, McKay JD, Smith GD, et al. Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. Cancer Epidemiol Biomarkers Prev 2011; 20 (10): 2250-2261. Epub 2011/08/25.
33. Munafo MR, Timofeeva MN, Morris RW, et al. Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. J Natl Cancer Inst 2012; 104 (10): 740-748. Epub 2012/04/27.
34. Ware JJ, van den Bree M, Munafo MR,. From men to mice: CHRNA5/CHRNA3, smoking behavior and disease. Nicotine Tob Res 2012; 14 (11): 1291-1299. Epub 2012/05/01.
35. Freathy RM, Ring SM, Shields B, et al. A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Hum Mol Gen 2009; 18 (15): 2922-2927. Epub 2009/05/12.
36. Munafo MR, Johnstone EC, Walther D, Uhl GR, Murphy MF, Aveyard P,. CHRNA3 rs1051730 genotype and short-term smoking cessation. Nicotine Tob Res 2011; 13 (10): 982-988. Epub 2011/06/22.
37. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ,. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011; 471 (7340): 597-601. Epub 2011/02/01.
38. Consortium TG,. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Gen 2010; 42 (5): 441-447. Epub 2010/04/27.
39. Freathy RM, Kazeem GR, Morris RW, et al. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol 2011; 40 (6): 1617-1628. Epub 2011/05/20.
40. Lewis SJ, Araya R, Smith GD, et al. Smoking is associated with, but does not cause, depressed mood in pregnancy-a Mendelian randomization study. PLoS One 2011; 6 (7): e21689. Epub 2011/08/06.
41. Cox JL, Holden JM, Sagovsky R,. Detection of postnatal depression. Development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry 1987; 150: 782-786. Epub 1987/06/01. (Pubitemid 17082036)
42. Bjorngaard JH, Gunnell D, Elvestad MB, et al. The causal role of smoking in anxiety and depression: a Mendelian randomization analysis of the HUNT study. Psychol Med 2012: 1-9. Epub 2012/06/13.
43. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta psychiatrica Scandinavica 1983; 67 (6): 361-370. Epub 1983/06/01. (Pubitemid 13098606)
44. Timpson NJ, Nordestgaard BG, Harbord RM, et al. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond) 2011; 35 (2): 300-308. Epub 2010/08/18.
45. Richmond R, Davey Smith G, Ness AR, den Hoed M, McMahon G, Timpson NJ,. Higher adiposity reduces physical activity levels in children: a Mendelian randomization analysis. Plos Med, under review.
46. Ripke S, Wray NR, Lewis CM, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18 (4): 497-511. Epub 2012/04/05.
47. Verweij KJ, Zietsch BP, Lynskey MT, et al. Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. Addiction 2010; 105 (3): 417-430. Epub 2010/04/21.
48. Pierce BL, VanderWeele TJ,. The effect of non-differential measurement error on bias, precision and power in Mendelian randomization studies. Int J Epidemiol 2012; 41 (5): 1383-1393. Epub 2012/10/10.
49. Timpson NJ, Sayers A, Davey-Smith G, Tobias JH,. How does body fat influence bone mass in childhood? A Mendelian randomization approach. J Bone Miner Res 2009; 24 (3): 522-533. Epub 2008/11/20.
50. Lee S, Wright FA, Zou F,. Control of population stratification by correlation-selected principal components. Biometrics 2011; 67 (3): 967-974. Epub 2010/12/08.
51. Rodriguez S, Gaunt TR, Day IN,. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 2009; 169 (4): 505-514. Epub 2009/01/08.
52. Cole SR, Platt RW, Schisterman EF, et al. Illustrating bias due to conditioning on a collider. Int J Epidemiol 2010; 39 (2): 417-420. Epub 2009/11/21.
53. Enomoto N, Takase S, Yasuhara M, Takada A,. Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin Exp Res 1991; 15 (1): 141-144. Epub 1991/02/01.
54. Matsuo K, Wakai K, Hirose K, Ito H, Saito T, Tajima K,. Alcohol dehydrogenase 2 His47Arg polymorphism influences drinking habit independently of aldehyde dehydrogenase 2 Glu487Lys polymorphism: analysis of 2,299 Japanese subjects. Cancer Epidemiol Biomarkers Prev 2006; 15 (5): 1009-1013. Epub 2006/05/17. (Pubitemid 43823531)
55. Hao PP, Chen YG, Wang JL, Wang XL, Zhang Y,. Meta-analysis of aldehyde dehydrogenase 2 gene polymorphism and Alzheimer's disease in East Asians. Can J Neurol Sci 2011; 38 (3): 500-506. Epub 2011/04/26.
56. Au, Yeung SL, Jiang CQ, Cheng KK, et al. Evaluation of moderate alcohol use and cognitive function among men using a Mendelian randomization design in the Guangzhou biobank cohort study. Am J Epidemiol 2012; 175 (10): 1021-1028. Epub 2012/02/04.
57. Wang J, Wang H, Chen Y, Hao P, Zhang Y,. Alcohol ingestion and colorectal neoplasia: a meta-analysis based on a Mendelian randomization approach. Colorectal Dis 2011; 13 (5): e71-e78. Epub 2010/12/01.
58. Boccia S, Hashibe M, Galli P, et al. Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev 2009; 18 (1): 248-254. Epub 2009/01/07.
59. Lewis SJ, Davey Smith G,. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev 2005; 14 (8): 1967-1971. Epub 2005/08/17. (Pubitemid 41161208)
60. Chen L, Davey Smith G, Harbord RM, Lewis SJ,. Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach. Plos Med 2008; 5 (3): e52. Epub 2008/03/06.